XML 21 R8.htm IDEA: XBRL DOCUMENT v3.21.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Restricted stock units
Common stock
Common stock
Restricted shares
Common stock
Restricted stock units
Additional capital in excess of par value
Additional capital in excess of par value
Restricted stock units
Retained earnings
AOCI
 [1]
Beginning balance (in shares) at Dec. 31, 2019     235,214,000            
Balances at beginning of period at Dec. 31, 2019 $ 7,102.1   $ 47.0     $ 654.6   $ 6,443.5 $ (43.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 1,589.3             1,589.3  
Other comprehensive income (loss), net of tax 0.3               0.3
Dividends declared (635.3)             (635.3)  
Shares issued upon option exercises (in shares)     1,856,000            
Shares issued upon option exercises 83.2   $ 0.4     82.8      
Restricted shares issued, net of shares withheld for taxes (in shares)       8,000          
Net shares issued upon vesting of restricted stock units (in shares)         60,000        
Net shares issued upon vesting of restricted stock units   $ (4.8)         $ (4.8)    
Stock-based compensation expense 164.3         164.3      
Restricted stock units issued as dividend equivalents           0.2   (0.2)  
Common shares repurchased (in shares)     (10,763,000)            
Common shares repurchased (1,170.6)   $ (2.1)     (242.5)   (926.0)  
Ending balance (in shares) at Sep. 30, 2020     226,375,000            
Balances at end of period at Sep. 30, 2020 7,128.5   $ 45.3     654.6   6,471.3 (42.7)
Beginning balances attributable to redeemable non-controlling interests at Dec. 31, 2019 1,121.0                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Net income (loss) attributable to redeemable non-controlling interests 4.4                
Other comprehensive income (loss), net of tax, attributable to redeemable non-controlling interests (13.9)                
Net redemptions from subscription into T. Rowe Price investment products 307.8                
Net consolidations deconsolidation of T. Rowe Price investment products (106.9)                
Ending balances attributable to redeemable non-controlling interests at Sep. 30, 2020 1,340.2                
Beginning balance (in shares) at Jun. 30, 2020     226,990,000            
Balances at beginning of period at Jun. 30, 2020 6,750.7   $ 45.4     654.6   6,102.9 (52.2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 643.2             643.2  
Other comprehensive income (loss), net of tax 9.5               9.5
Dividends declared (210.2)             (210.2)  
Shares issued upon option exercises (in shares)     492,000            
Shares issued upon option exercises 26.0   $ 0.1     25.9      
Net shares issued upon vesting of restricted stock units (in shares)         17,000        
Net shares issued upon vesting of restricted stock units   (1.6)         (1.6)    
Stock-based compensation expense 52.8         52.8      
Restricted stock units issued as dividend equivalents           0.1   (0.1)  
Common shares repurchased (in shares)     (1,124,000)            
Common shares repurchased (141.9)   $ (0.2)     (77.2)   (64.5)  
Ending balance (in shares) at Sep. 30, 2020     226,375,000            
Balances at end of period at Sep. 30, 2020 7,128.5   $ 45.3     654.6   6,471.3 (42.7)
Beginning balances attributable to redeemable non-controlling interests at Jun. 30, 2020 1,090.1                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Net income (loss) attributable to redeemable non-controlling interests 55.4                
Other comprehensive income (loss), net of tax, attributable to redeemable non-controlling interests (20.8)                
Net redemptions from subscription into T. Rowe Price investment products 217.9                
Net consolidations deconsolidation of T. Rowe Price investment products (44.0)                
Ending balances attributable to redeemable non-controlling interests at Sep. 30, 2020 1,340.2                
Beginning balance (in shares) at Dec. 31, 2020     227,965,000            
Balances at beginning of period at Dec. 31, 2020 7,707.0   $ 45.6     654.6   7,029.8 (23.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 2,342.3             2,342.3  
Other comprehensive income (loss), net of tax (6.4)               (6.4)
Dividends declared (754.8)             (754.8)  
Special cash dividends declared $ (699.5)             (699.5)  
Shares issued upon option exercises (in shares) 1,403,996   1,083,000            
Shares issued upon option exercises $ 38.8   $ 0.2     38.6      
Restricted shares issued, net of shares withheld for taxes (in shares)       4,000          
Net shares issued upon vesting of restricted stock units (in shares)         54,000        
Net shares issued upon vesting of restricted stock units   (4.8)         (4.8)    
Stock-based compensation expense 166.2         166.2      
Restricted stock units issued as dividend equivalents (0.1)         0.6   (0.7)  
Common shares repurchased (in shares)     (2,889,000)            
Common shares repurchased (526.6)   $ (0.6)     (200.6)   (325.4)  
Ending balance (in shares) at Sep. 30, 2021     226,217,000            
Balances at end of period at Sep. 30, 2021 8,262.1   $ 45.2     654.6   7,591.7 (29.4)
Beginning balances attributable to redeemable non-controlling interests at Dec. 31, 2020 1,561.7                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Net income (loss) attributable to redeemable non-controlling interests 22.6                
Other comprehensive income (loss), net of tax, attributable to redeemable non-controlling interests 20.2                
Net redemptions from subscription into T. Rowe Price investment products 6.1                
Net consolidations deconsolidation of T. Rowe Price investment products (483.6)                
Ending balances attributable to redeemable non-controlling interests at Sep. 30, 2021 1,086.6                
Beginning balance (in shares) at Jun. 30, 2021     226,925,000            
Balances at beginning of period at Jun. 30, 2021 7,893.0   $ 45.4     673.7   7,202.6 (28.7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 777.2             777.2  
Other comprehensive income (loss), net of tax (0.7)               (0.7)
Dividends declared (250.7)             (250.7)  
Shares issued upon option exercises (in shares)     321,000            
Shares issued upon option exercises 9.0         9.0      
Net shares issued upon vesting of restricted stock units (in shares)         5,000        
Net shares issued upon vesting of restricted stock units   $ (0.5)         $ (0.5)    
Stock-based compensation expense 52.3         52.3      
Restricted stock units issued as dividend equivalents 0.2         0.4   (0.2)  
Common shares repurchased (in shares)     (1,034,000)            
Common shares repurchased (217.7)   $ (0.2)     (80.3)   (137.2)  
Ending balance (in shares) at Sep. 30, 2021     226,217,000            
Balances at end of period at Sep. 30, 2021 8,262.1   $ 45.2     $ 654.6   $ 7,591.7 $ (29.4)
Beginning balances attributable to redeemable non-controlling interests at Jun. 30, 2021 880.4                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Net income (loss) attributable to redeemable non-controlling interests (19.8)                
Other comprehensive income (loss), net of tax, attributable to redeemable non-controlling interests 12.2                
Net redemptions from subscription into T. Rowe Price investment products (292.8)                
Net consolidations deconsolidation of T. Rowe Price investment products 531.0                
Ending balances attributable to redeemable non-controlling interests at Sep. 30, 2021 $ 1,086.6                
[1] Accumulated other comprehensive income.